Diagnostics World Asia Conference

Upload
tonkin-corporation-pte-ltd
Category

Health & Medicine
view
426
download
2

Embed Size (px):

description

Diagnostics World Asia Conference will focus on infectious disease and cancer diagnostics in the rapidly growing area of diagnostics based on molecular detection i.e. nucleic acid-based and immuno-diagnostics. Asia represents an important market and a fertile ground for emerging companies with competitive diagnostics technologies and products. The success of translating a discovery into a useful clinical tool and launching the product onto the market requires a winning combination of access to suitable enabling technology, freedom-to-operate , obtaining quality and market authorization standards, end-user friendliness, ability to meet an unmet medical need as well as strategic pricing and positioning . This conference will address the above issues and endeavors to bring together the experience and insights from the innovators, developers, manufacturers, end –users as well as solution and service providers. This conference will bring together the main elements and key players involved in the complex and specialized process of bringing clinically-relevant and commercially viable diagnostic products to market. The event will focus on overcoming the commercialisation hurdles as well as showcase the existing and future opportunities for growth in Asia and beyond. Who Should Attend Diagnostics World Asia: • Diagnostic Companies in the area or interested molecular and immuno-diagnostics and opportunities for growth in Asia • Researchers/innovators with cutting-edge discoveries in the field of biomarkers and detection methodologies interested in the translation of their research into diagnostic products • Clinicians involved in the development and clinical validation of diagnostic tests • Lab Managers/ Directors of public and private diagnostic testing services • Investors looking to fund diagnostics ventures • Service and solution providers supporting the development, manufacturing, marketing and distribution of diagnostic products • Pharma companies who would like to know more about the value proposition for companion Dx or are looking for partners to develop companion Dx for their product pipelines • Government bodies, regulators and associations with interest in the diagnostics industry Event Highlights: • Evaluation of Standards for Use of IVD for Infectious Diseases • Frontiers of Personalized Medicine: Strategy for Simultaneous Co-development of New Drugs and Diagnostics • Evaluation of Biological Risks Using Diagnostics • Turning Water into Wine: Personalised Medicine in Cancer • Analysis of Various Approaches to Mycotoxin Analysis • How Public and Private Sectors Can Work Together to Develop Dx to Meet Unmet Medical and Healthcare Needs • From Novel Markers to Diagnostic test – The IP hurdles • Diagnostics for Emerging Infectious Diseases • Capitalising on Biomarkers as a Tool for Patient Stratification: Approaches for Identifying Biomarkers for Patient Stratification • Overcoming Key Challenges for POC Diagnostics for Successful Implementation • Partnering Opportunities in Molecular Diagnostics • Clinical viability of POC: Ensuring your POC /Dx products fit into the Patient Management Paradigm and Minimizing the Risk of Technical Failure • Addressing Patient & Healthcare Provider Requirements and Integrating Technology to come up with Commercially Successful Dx Products • Defining the Role of Diagnostics in Dengue Control and Vector-borne Disease